Placeholder Banner

Select Committee on Climate Crisis: BIO Comments on Public Policies Needed to Help Biotech Address Climate Change

December 20, 2019

The Biotechnology Innovation Organization (BIO) is pleased to respond to the Select Committee's Request for Information (RFI) on how supportive public policy can help biotechnology reduce greenhouse gas emissions, enhance carbon sequestration, mitigate the effects of climate change, enhance public response to public health emergencies, and speed the transition of the U.S. economy to one that is more bio-based—benefiting the environment, public health, and our national economy. 

Download Full Comments Below
BIO Comments on Public Policy Needed to Enable Biotech to Address Climate Crisis
Discover More
January 7, 2020 Re: Docket No. FDA–2019-N-3453: Promoting Effective Drug Development Programs: Opportunities and Priorities for the Food and Drug Administration's Office of New Drugs Dear Sir/Madam: The Biotechnology Innovation Organization (BIO…
January 4, 2020 Re: Docket No. FDA–2019-N-5157: 2019 Public Meeting on Center for Drug Evaluation and Research Standard Core Sets: Clinical Outcome Assessments and Endpoints Grant Program. Dear Sir/Madam: The Biotechnology Innovation Organization…
On December 16, 2019, the Biotechnology Innovation Organization (BIO) provided comments on the Food and Drug Administration’s (FDA’s) Notice to Public of Website Location of CDRH Fiscal Year 2020 Proposed Guidance Development; In Vitro…